Drugs bill to soar by €30m

The HSE is faced with an unplanned €30m bill for providing drugs not contained in its national service plan for 2012.

Drugs bill to soar by €30m

A significant part of the cost, between €8m to €10m, will be in providing two Hepatitis C drugs, Boceprevir and Telaprevir.

The drugs were made available in June following the intervention of the Department of Health.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited